Trial intelligence / Profile preview

Lithium plus Equetro for Rapid Cycling Bipolar Disorder

NCT00325286Phase 4Unknown

Sponsor
Creighton University
Start
May 2006
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of carbamazepine in bipolar disorder (BD), sponsored by Creighton University. Status: unknown.

02

Drugs

carbamazepine
03

Conditions

bipolar disorder (BD)

Beyond the preview

Go deeper on NCT00325286.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00325286.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call